# National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD – FDA Inspections

Source: https://www.keypedia.com/companies/national-cancer-institute-cancer-therapy-evaluation-program/8cc7f4d2-3770-43d0-adba-33439499bb74

> Inspection records and compliance data for National Cancer Institute, Cancer Therapy Evaluation Program in Bethesda, Maryland. 2 FDA inspections on record, last inspected January 10, 2020.

---

## Details

- Name: National Cancer Institute, Cancer Therapy Evaluation Program
- FEI Number: 3010830399
- Address Line 1: 31 Center Dr.
- City: Bethesda
- State: Maryland
- Zip Code: 20892
- Country Name: United States
- Address: 31 Center Dr., Bethesda, Maryland 20892, United States
- Country: United States

## Related Documents

- FDA Inspection 1118260 - National Cancer Institute, Cancer Therapy Evaluation Program - 2020-01-10 — classification: No Action Indicated (NAI), source: FDA, date: January 10, 2020
- [483 - National Cancer Institute, Cancer Therapy Evaluation Program - 2014-07-17](https://www.keypedia.com/records/483/national-cancer-institute-cancer-therapy-evaluation-program/df2145ec-53be-4693-bace-5d10a2c865b2) — source: FDA, date: July 17, 2014
- [EIR - National Cancer Institute, Cancer Therapy Evaluation Program - 2014-07-17](https://www.keypedia.com/records/eir/national-cancer-institute-cancer-therapy-evaluation-program/0ea41923-e58e-4119-93c8-059ec001ad62) — source: FDA, date: July 17, 2014
- [FDA Inspection 891981 - National Cancer Institute, Cancer Therapy Evaluation Program - 2014-07-17](https://www.keypedia.com/records/fda_inspections/national-cancer-institute-cancer-therapy-evaluation-program/3b211a2b-f2f0-4ba6-abdf-e658b694e7ce) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 17, 2014

## Related Companies

- [Tae H. Chung, M.D.](https://www.keypedia.com/companies/tae-h-chung-md/a30fcc9e-9af9-4eaf-ada7-d66551d9318e)
- [Warner Graham LLLP](https://www.keypedia.com/companies/warner-graham-lllp/b7f7ddcd-3aa8-4189-8732-9a854956ce5f)
- [Medicine Invention Design Incorporation IRB](https://www.keypedia.com/companies/medicine-invention-design-incorporation-irb/e44eb96d-12cf-40b4-bad0-077b64ce61fd)
- [Leadiant Biosciences, Inc.](https://www.keypedia.com/companies/leadiant-biosciences-inc/96da3cf1-2605-43f0-b819-2daa4c14e527)
- [Michael J. Polydefkis, M.D.](https://www.keypedia.com/companies/michael-j-polydefkis-md/f67f7603-94b9-4cb8-a7c5-90751ac1dce1)
- [Wanzhu Hou, CMD, MD (CN)](https://www.keypedia.com/companies/wanzhu-hou-cmd-md-cn/e1608fee-f767-4781-98f2-bc27db2520e2)
- [Reveragen Biopharma Inc.](https://www.keypedia.com/companies/reveragen-biopharma-inc/eaf70eaf-05c9-4025-b737-094553dcf19f)
- [John J. Wroblewski, M.D.](https://www.keypedia.com/companies/john-j-wroblewski-md/152a4c6a-a7f1-43ad-a4ab-ab9c6b949452)
- [PAREXEL Early Phase Clinical Unit](https://www.keypedia.com/companies/parexel-early-phase-clinical-unit/9748c7f3-64a9-490d-994d-e02b56d9d1d0)
- [Julie Hoover-Fong, M.D.](https://www.keypedia.com/companies/julie-hoover-fong-md/521b2290-db8f-42a2-90b0-c35343e30f31)

## Related Officers

- [investigator](https://www.keypedia.com/people/courtney-n-long/32118415-bc77-4ac2-8f90-947e43cf10ff)
- [company_representative](https://www.keypedia.com/people/karen-said/01c658cb-f919-414e-bafd-4afc869c6eb3)
- [company_representative](https://www.keypedia.com/people/l-mary-smith/0a0b6b86-4e5c-477f-b246-bea80e1547a4)
